Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily, With Emtricitabine and Tenofovir Disoproxil Fumarate, for Previously Untreated HIV-1 Infection: Week 96 Results From ONCEMRK, a Randomized, Double-Blind, Noninferiority Trial

Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily, With Emtricitabine and Tenofovir Disoproxil Fumarate, for Previously Untreated HIV-1 Infection: Week 96 Results From ONCEMRK, a Randomized, Double-Blind, Noninferiority Trial

Item

http://www.wikidata.org/entity/Q56988548

Q56988548

about

Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily, With Emtricitabine and Tenofovir Disoproxil Fumarate, for Previously Untreated HIV-1 Infection: Week 96 Results From ONCEMRK, a Randomized, Double-Blind, Noninferiority Trial

Item

http://www.wikidata.org/entity/Q56988548

description

article

@en

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Raltegravir 1200 mg Once Daily ...... le-Blind, Noninferiority Trial

@en

Raltegravir 1200 mg Once Daily ...... le-Blind, Noninferiority Trial

@nl

type

Item

label

Raltegravir 1200 mg Once Daily ...... le-Blind, Noninferiority Trial

@en

Raltegravir 1200 mg Once Daily ...... le-Blind, Noninferiority Trial

@nl

prefLabel

Raltegravir 1200 mg Once Daily ...... le-Blind, Noninferiority Trial

@en

Raltegravir 1200 mg Once Daily ...... le-Blind, Noninferiority Trial

@nl

P1476

Raltegravir 1200 mg Once Daily ...... le-Blind, Noninferiority Trial

@en

P2093

Bach-Yen Nguyen

http://www.w3.org/2001/XMLSchema#string

Brenda Homony

http://www.w3.org/2001/XMLSchema#string

Deborah Hepler

http://www.w3.org/2001/XMLSchema#string

George J Hanna

http://www.w3.org/2001/XMLSchema#string

Hedy Teppler

http://www.w3.org/2001/XMLSchema#string

Jean-Michel Molina

http://www.w3.org/2001/XMLSchema#string

Kathleen Squires

http://www.w3.org/2001/XMLSchema#string

Mark Bloch

http://www.w3.org/2001/XMLSchema#string

Mohammed Rassool

http://www.w3.org/2001/XMLSchema#string

Paul E Sax

http://www.w3.org/2001/XMLSchema#string

P2860

Influence of Sex/Gender and Race on Responses to Raltegravir Combined With Tenofovir-Emtricitabine in Treatment-Naive Human Immunodeficiency Virus-1 Infected Patients: Pooled Analyses of the STARTMRK and QDMRK Studies.

Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial.

Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.

Safety, tolerability, and efficacy of raltegravir in a diverse cohort of HIV-infected patients: 48-week results from the REALMRK Study.

Brief Report: Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results From the SINGLE Randomized Clinical Trial.

Better adherence with once-daily antiretroviral regimens: a meta-analysis

Raltegravir as antiretroviral therapy in HIV/AIDS.

Pharmacokinetic and pharmacodynamic evaluation of raltegravir and experience from clinical trials in HIV-positive patients.

Critical Review: Review of the Efficacy, Safety, and Pharmacokinetics of Raltegravir in Pregnancy.

P304

589-598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAI.0000000000001723

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29771789

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease

P932

6075877

http://www.w3.org/2001/XMLSchema#string

Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily, With Emtricitabine and Tenofovir Disoproxil Fumarate, for Previously Untreated HIV-1 Infection: Week 96 Results From ONCEMRK, a Randomized, Double-Blind, Noninferiority Trial

about

Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily, With Emtricitabine and Tenofovir Disoproxil Fumarate, for Previously Untreated HIV-1 Infection: Week 96 Results From ONCEMRK, a Randomized, Double-Blind, Noninferiority Trial

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932